Galapagos

Galapagos is a biotechnology company focused on the discovery and development of small molecule medicines with novel modes of action. They generate revenue through partnerships, licensing agreements, and the commercialization of their proprietary drugs. Founded in 1999 in Belgium, the company has a strong pipeline in various stages of clinical trials, particularly in inflammation, fibrosis, and other diseases. Their collaboration with Gilead Sciences on the drug filgotinib is a notable milestone in their history.

Recent Posts by Galapagos

1-5 of 5